...
首页> 外文期刊>Journal of vascular nursing: official publication of the Society for Peripheral Vascular Nursing >Review of an Article: Aspirin for primary prevention of cardiovascular events in people with diabetes. (2010). A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
【24h】

Review of an Article: Aspirin for primary prevention of cardiovascular events in people with diabetes. (2010). A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.

机译:一篇文章的评论:阿司匹林用于糖尿病人的心血管事件的一级预防。 (2010)。美国糖尿病协会(ADA)的立场声明,美国心脏协会(AHA)的科学声明以及美国心脏病学会基金会(ACCF)的专家共识文件。糖尿病护理33:6; 2010年6月; 1395-1402。

获取原文
获取原文并翻译 | 示例
           

摘要

Aspirin has been effective in reducing cardiovascular morbidity and mortality in high-risk patients with myocardial infarction (MI) or stroke. There is conflicting evidence about the use of as-piriri (ASA) for primary prevention of cardiovascular disease (CVD) in patients with diabetes. The current evidence includes several randomized trials that examined ASA for primary prevention of CVD in patients with diabetes: 3 trials specifically for diabetics and 6 trials in which diabetics were in subgroups.
机译:阿司匹林已有效降低患有心肌梗塞(MI)或中风的高危患者的心血管疾病发病率和死亡率。关于使用as-piriri(ASA)预防糖尿病患者的心血管疾病(CVD)的证据相互矛盾。目前的证据包括一些随机试验,这些试验检查了ASA在糖尿病患者中对CVD的一级预防作用:3个专门针对糖尿病患者的试验和6个糖尿病患者属于亚组的试验。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号